The synthetic oleanane triterpenoids and the histone deacetylase inhibitor vorinostat cooperate to delay tumor development in a transgenic model of estrogen receptor-negative breast cancer

Abstract 820: The synthetic triterpenoids, CDDO-methyl ester and CDDO-ethyl amide, and the histone deacetylase inhibitor vorinostat delay carcinogenesis in a transgenic model of estrogen receptor-negative breast cancer

10.1158/1538-7445.am2011-820 ◽

2011 ◽

Author(s):

Kim M. Tran ◽

Michael B. Sporn ◽

Karen Liby

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Methyl Ester ◽

Histone Deacetylase ◽

Histone Deacetylase Inhibitor ◽

Transgenic Model ◽

Deacetylase Inhibitor ◽

Estrogen Receptor Negative

Download Full-text

Lipid rafts remodeling in estrogen receptor–negative breast cancer is reversed by histone deacetylase inhibitor

Molecular Cancer Therapeutics ◽

10.1158/1535-7163.mct-05-0226 ◽

2006 ◽

Vol 5 (2) ◽

pp. 238-245 ◽

Cited By ~ 17

Author(s):

Anna Ostapkowicz ◽

Kunihiro Inai ◽

Leia Smith ◽

Silvia Kreda ◽

Jozef Spychala

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Histone Deacetylase ◽

Lipid Rafts ◽

Histone Deacetylase Inhibitor ◽

Deacetylase Inhibitor ◽

Estrogen Receptor Negative

Download Full-text

Synergistic epigenetic reactivation of estrogen receptor-alpha (ERalpha) by combined green tea polyphenol and histone deacetylase inhibitor in ERalpha-negative breast cancer cells

Molecular Cancer ◽

10.1186/1476-4598-9-274 ◽

2010 ◽

Vol 9 (1) ◽

pp. 274 ◽

Cited By ~ 115

Author(s):

Yuanyuan Li ◽

Yih-Ying Yuan ◽

Syed M. Meeran ◽

Trygve O. Tollefsbol

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Histone Deacetylase ◽

Green Tea ◽

Histone Deacetylase Inhibitor ◽

Breast Cancer Cells ◽

Estrogen Receptor Alpha ◽

Tea Polyphenol ◽

Deacetylase Inhibitor ◽

Green Tea Polyphenol

Download Full-text

The histone deacetylase inhibitor trichostatin A sensitizes estrogen receptor α-negative breast cancer cells to tamoxifen

Oncogene ◽

10.1038/sj.onc.1207315 ◽

2003 ◽

Vol 23 (9) ◽

pp. 1724-1736 ◽

Cited By ~ 102

Author(s):

Eun Ryoung Jang ◽

Soo-Jeong Lim ◽

Eun Sook Lee ◽

Gajin Jeong ◽

Tae-You Kim ◽

...

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Cancer Cells ◽

Histone Deacetylase ◽

Histone Deacetylase Inhibitor ◽

Breast Cancer Cells ◽

Trichostatin A ◽

Estrogen Receptor Α ◽

Deacetylase Inhibitor ◽

Histone Deacetylase Inhibitor Trichostatin

Download Full-text

The histone deacetylase inhibitor trichostatin A sensitizes estrogen receptor alpha-negative breast cancer cells to tamoxifen

The Women s Oncology Review ◽

10.3109/14733400412331313133 ◽

2004 ◽

Vol 4 (3) ◽

pp. 187-189

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Cancer Cells ◽

Histone Deacetylase ◽

Histone Deacetylase Inhibitor ◽

Breast Cancer Cells ◽

Estrogen Receptor Alpha ◽

Trichostatin A ◽

Deacetylase Inhibitor ◽

Histone Deacetylase Inhibitor Trichostatin

Download Full-text

The histone deacetylase inhibitor trichostatin A sensitizes estrogen receptor alpha-negative breast cancer cells to tamoxifen

The Women s Oncology Review ◽

10.1080/14733400412331313133 ◽

2004 ◽

Vol 4 (3) ◽

pp. 187-189

Author(s):

Not Available Not Available

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Cancer Cells ◽

Histone Deacetylase ◽

Histone Deacetylase Inhibitor ◽

Breast Cancer Cells ◽

Estrogen Receptor Alpha ◽

Trichostatin A ◽

Deacetylase Inhibitor ◽

Histone Deacetylase Inhibitor Trichostatin

Download Full-text

A Novel Histone Deacetylase Inhibitor, Scriptaid, Enhances Expression of Functional Estrogen Receptor α (ER) in ER negative human breast cancer cells in combination with 5-aza 2′-deoxycytidine

Breast Cancer Research and Treatment ◽

10.1023/a:1026146524737 ◽

2003 ◽

Vol 81 (3) ◽

pp. 177-186 ◽

Cited By ~ 108

Author(s):

Judith Clancy Keen ◽

Lan Yan ◽

Kelly M. Mack ◽

Catherine Pettit ◽

Dawn Smith ◽

...

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Histone Deacetylase ◽

Histone Deacetylase Inhibitor ◽

Human Breast Cancer ◽

Breast Cancer Cells ◽

Estrogen Receptor Α ◽

Human Breast Cancer Cells ◽

Human Breast ◽

Deacetylase Inhibitor

Download Full-text

Histone deacetylase inhibitor suberoyl bis-hydroxamic acid suppresses cell proliferation and induces apoptosis in breast cancer cells

Molecular Medicine Reports ◽

10.3892/mmr.2014.3076 ◽

2014 ◽

Vol 11 (4) ◽

pp. 2908-2912 ◽

Cited By ~ 3

Author(s):

XINMIAO YANG ◽

NING ZHANG ◽

ZELIANG SHI ◽

ZHANGYU YANG ◽

XICHUN HU

Keyword(s):

Breast Cancer ◽

Cell Proliferation ◽

Cancer Cells ◽

Histone Deacetylase ◽

Histone Deacetylase Inhibitor ◽

Hydroxamic Acid ◽

Breast Cancer Cells ◽

Deacetylase Inhibitor

Download Full-text

The histone deacetylase inhibitor trichostatin A alters microRNA expression profiles in apoptosis-resistant breast cancer cells

Oncology Reports ◽

10.3892/or.2011.1488 ◽

2011 ◽

Cited By ~ 4

Author(s):

Bridgette Collins-Burow

Keyword(s):

Breast Cancer ◽

Cancer Cells ◽

Histone Deacetylase ◽

Histone Deacetylase Inhibitor ◽

Breast Cancer Cells ◽

Trichostatin A ◽

Expression Profiles ◽

Microrna Expression ◽

Deacetylase Inhibitor ◽

Histone Deacetylase Inhibitor Trichostatin

Download Full-text

Phase I-II study of the histone deacetylase inhibitor (HDACi) vorinostat plus paclitaxel and bevacizumab in metastatic breast cancer (MBC): New York Cancer Consortium trial P7703.

10.1158/0008-5472.sabcs-404 ◽

2009 ◽

Cited By ~ 4

Author(s):

B Ramaswamy ◽

K Bhalla ◽

B Cohen ◽

C Pellegrino ◽

D Hershman ◽

...

Keyword(s):

Breast Cancer ◽

New York ◽

Metastatic Breast Cancer ◽

Phase I ◽

Histone Deacetylase ◽

Histone Deacetylase Inhibitor ◽

Metastatic Breast ◽

Deacetylase Inhibitor

Download Full-text